Browsing: AI News

ST. LOUIS, Aug. 6, 2026 /PRNewswire/ — Global automation leader Emerson (NYSE: EMR) today announced it has acquired Glue Inc., an innovator in advancing intelligent validation and test through its AI-enabled software product Glue Studio. Glue Studio features specialized AI-centric capabilities for test generation and planning. The acquisition strengthens Emerson’s strategy to deliver more software-defined,…

Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers.

Rocketing and outrageous valuations, incestuous funding models, sketchy business plans, deepening losses,technology claimsso implausible they would have a reader of the wackiest science-fiction novel struggling to suspend disbelief. AI now has all the hallmarks of a monstrous bubble, including the denials of its evangelists that stocks are wildly overvalued. Sober comparisons with the dotcom bubble…

NIST Joins National Genesis Mission to Accelerate AI Innovation | NIST Skip to main content

She began writing straight out of college, freelanced for years and eventually followed a path taken by many young Filipinos: joining a multinational in the country’s booming outsourcing industry.

Editor’s note: Today, Google and Alphabet CEO Sundar Pichai shared some changes with Google DeepMind teams, including new roles for Demis Hassabis and Koray Kavukcuoglu. Below are the messages Sundar and Demis sent to employees.

Two of the world’s most powerful AI tools created fake human profiles to try and trick people in an attempted cyber-attack during testing by the UK’s AI Security Institute (AISI).

Here’s a recap of some of our biggest AI updates from July, including three new Gemini models for building AI agents at scale and Gemini Robotics ER 2 to help robots reason, collaborate, and solve real-world tasks.

If you have used a free version of ChatGPT or any of its AI rivals, then you are obviously getting a good deal.

Researchers from Cleveland Clinic and IBM have jointly developed a framework for using quantum computing to make predictions of antigen presentation and immunotherapy response, according to the study results published in Science Advances.